ÔÚÍâÓÃÆ¤ÖÊÀà¹Ì´¼¼¤Ëس·Ò©¹ý³ÌÖгöÏÖµÄÑÓ
PeterGust,BS,aandSbaronE.Jacob,MDb
¸ø±à¼µÄÐÅ£ºÎÒÃÇÔÞͬHajarµÈ1ÈËÔÚÆäÖØÒª×ÛÊöÖжÔÍâÓÃÆ¤ÖÊÀà¹Ì´¼¼¤Ëس·Ò©£¨TSW£©ºÍÉÏñ«×ÛºÏÕ÷ÎÄÏ×µÄ×ܽᡣÀà¹Ì´¼¼¤ËØÒ»Ö±ÊǸ÷ÖÖÆ¤·ô¼²²¡µÄ¾µäÖÎÁÆÒ©Îï¡£HajarµÈ1ÈËÃèÊöµÄTSWµÄÏà¹ØÌØÕ÷Ó¡Ö¤ÁËÎÒÃǵÄÁÙ´²¾Ñ飬°üÀ¨Ã沿µäÐͺì°ß¡¢×ÆÈÈ¡¢´ÌÍ´¸Ð£¬ÒÔ¼°Å®ÐÔΪÖ÷µÄÈË¿Úͳ¼ÆÑ§½á¹û¡£
ÎÒÃǹ۲쵽2ÀýÅ®ÐÔ²¡È˾ù³öÏÖÏàËÆµÄÉÏÊöÁÙ´²±íÏÖ£¬¶øÇÒÐèÒª¾¯ÌèµÄÊÇËýÃdzöÏÖÁËÏà¹ØµÄ³Ù·¢ÐÔ°ßÌùʵÑé·´Ó¦¡£2Àý²¡È˾ù³¤ÆÚÓÚÃæ²¿Í¿Ä¨BÀàÍâÓÃÌÇÆ¤Öʼ¤ËØ£¨Ò»ÀýΪÇú°²Ä壬ÁíÒ»ÀýΪµØÄ壩2¡£2Àý²¡È˾ù³ÊÏÖ³Ù·¢ÐÔ°ßÌùÊÔÑéÑôÐÔ½á¹û¡£µÚÒ»Àý²¡ÈËÓè0.1%Çú°²ÄεºÍ0.1%²¼µØÄε½øÐаßÌùÊÔÑ飨chemotechnique,Vellinge£¬Sweden£©£¬ÓÚ48ºÍ96Сʱ½øÐеÚÒ»´Î½á¹ûÅжÁ¡£½á¹ûÏÔʾËý¶Ô·¼Ïã»ìºÏÎï1£¨2+£©£¬Èâ¹ðÈ©£¨1+£©£¬±½¼×´¼ÑôÐÔ£¬µ«ÌÇÆ¤Öʼ¤Ëؽá¹ûΪÒõÐÔ¡£°ßÌùÎïÖÜΧÓÐÑÏÖØµÄºì°ß£¬ÓÚÊÇËý±»¸æÖªÐèÒª±ÜÃâ·¼Ïã»ìºÏÎï¡£ÎÒÃǽ¨ÒéËýÒ»µ©³öÏÖÈÎÒ½Ôº¡£°ßÌùÊÔÑé20Ììºó²¼µØÄεºÍÇú°²Äε°ßÌù´¦³öÏÖÑôÐÔ2+¡£Ëý¼ÌÐø¼ä¶ÏʹÓÃÇú°²ÄεÂÈí¸à£¬Ã沿ƤÑ×È´ÈÔδ¸ÄÉÆ¡£µÚ¶þ¸ö²¡ÈËÓÚ°ßÌùÊÔÑéÑôÐÔ21ÌìÒòÃæ²¿Ö¢×´¶ñ»¯¶ø¸´ÕÆä²¼µØÄε°ßÌù´¦³öÏÖÁËÑôÐÔ2+£¨TRUETest£¬Smartpractice£¬Phoenix£¬AZ£©¡£
Öð½¥¼õÁ¿ÍâÓõÄÌÇÆ¤Öʼ¤ËØÍ¬Ê±Ê¹Óþֲ¿µÄÃâÒßµ÷½Ú¼Áºó£¬2Àý²¡È˵ÄÁÙ´²Ö¢×´ÓÐÏÔÖøµÄ¸ÄÉÆ¡£Ò»¸ö¹ØÓÚTSWºÍÍâÓÃÌÇÆ¤Öʼ¤ËسÉñ«µÄÏàËÆÑо¿Ö¤Ã÷°´°ßÌù±ê×¼²½Öè3ʵʩÌÇÆ¤Öʼ¤ËذßÌùÊÔÑéÎÞÏà¹ØµÄÑôÐÔ½á¹û¡£ÎÒÃÇÈÏΪÐ迼ÂÇÑӳٵijٷ¢ÐÔ·´Ó¦£¨£¾7Ì죩µÄ¿ÉÄÜÐÔ¡£
ÌÇÆ¤Öʼ¤ËØËùÖ½Ӵ¥ÐÔÆ¤Ñ׿ÉÄܳ£³£´æÔÚÓÚTSW²¡ÈËÖС£ÎÒÃǽ¨ÒéÈç¹û¸ß¶È»³ÒÉTSW£¬²¡ÈËÓ¦¸Ã±ÜÃâʹÓÃÕâÀàÒ©ÎͬʱÐèÐаßÌùÊÔÑ飬²¢ÇÒÐ迼ÂÇÑӳٵijٷ¢ÐÔÑôÐÔ·´Ó¦µÄ¿ÉÄÜÐÔ£¬ÒòΪ¡°ÎÒÃDz»Ó¦¸ÃÍü¼ÇÓÃÌÇÆ¤Öʼ¤ËØÀ´ÖÎÁƱäÓ¦ÐÔ½Ó´¥ÐÔÆ¤Ñ×£¨ACD£©Ò²¿ÉÄܵ¼Ö²¡È˳öÏÖACD4¡£¡±
Fundingsources:None
Disclosures:Dr.JacobisfounderandCEOofDermatitisAcademy.Anopen-accesscontactdermatitisEsourcewitbanaffiliatedAZOVAonlineDTCteledermatologyclinicservingtheneedsofpatientswitbcontactdermatitisandservedascoordinatingprincipalinvestigatorforthesafetyandefficacyofTrueTest(SmarPractice)panels1.1,2.1,and3.1inchildrenandadolescentsandthePediatricResearchEquityAct(PREA-1)trial,andhasservedasaconsultantforjohnson
JAAD²Î¿¼ÎÄÏ×1.HajarT,LeshemYA,HanifinJM,etal.Asystematicreviewoftopicalcorticosteroidwithdrawal(¡®¡®steroidaddiction¡¯¡¯)inpa-tientswithatopicdermatitisandotherdermatoses.JAmAcadDermatol.;72:-.
2.JacobSE,SteeleT.Corticosteroidclasses:aquickreference.JAmAcadDermatol.;54:-.
3.RapaportMJ,LebwohlM.Corticosteroidaddictionandwith-drawalintheatopic:theredburningskinsyndrome.ClinDermatol.;21:-.
4.G€on€ulM,G€ulU.Detectionofcontacthypersensitivitytocorticosteroidsinallergiccontactdermatitispatientswhodonotrespondtotopicalcorticosteroids.ContactDermatitis.;53:67-70.
E-mail:sjacob
contactderm.net£¨Ö÷Ì⸺ÔðÈË£ºÒ¦Ö¾ÈÙ£»ÉóУ£º³ÂÌηÒ룺ÂíÇïÓ¢»ªÖпƼ¼´óѧͬҽԺ£©
1¡¢ËÑË÷£ºÆ»¹ûÊÖ»úÔÚ¡°AppStore¡±£¬°²×¿ÊÖ»ú¿ÉÔÚ¡°ÊÖ»úÖúÊÖ¡±»ò¡°Íã¶¹¼ÔÓ¦ÓÃÊг¡¡±£¬ËÑË÷¡°Æ¤¿ÆÊ±Ñ¶ÂÛ̳¡±ÏÂÔØ°²×°¡£
2¡¢É¨Ã裺ɨÃè°×µß·è°×ñ°·ç¿ÉÒÔÒ½ÖÎÂð
- ÉÏһƪÎÄÕ£º ÈÕ±¾VGˮͷƤʪÕîͷƤм֬ÒçÐÔ
- ÏÂһƪÎÄÕ£º ¶¬²¡ÏÄÖκÃʱ½ÚѨλÌù·óÕýµ±Ê±å§ÑôÊÐ

- ƤÑ׵IJ¡ÒòÓÐÄÄЩ·½2013-1-1
- Ö¬ÒçÐÔÆ¤Ñ׵IJ¡ÒòÓÐ2013-1-4
- µ¼Ö¹ýÃôÐÔÆ¤Ñ×·¢²¡2013-1-7
- ƽʱӦ¸ÃÔõôԤ·ÀÖ¬2013-11-19
- ¶Ô¹¤×÷µÄ¸ß¶ÈÔðÈθÐ2015-11-17

- ƤÑ׵IJ¡ÒòÓÐÄÄЩ·½Ãæ2013-1-1
- Ö¬ÒçÐÔÆ¤Ñ׵IJ¡ÒòÓÐʲ2013-1-4
- µ¼Ö¹ýÃôÐÔÆ¤Ñ×·¢²¡Ô2013-1-7
- ²»ÆðÑ۵ĹÜ×ӶԴ˲¡»¼2011-11-9
- ÕÒµ½ºÃµÄÔ±¹¤ÒªÓкõÄ2011-11-9

- ¡¤ÈÈÁÒ×£ºØÎÒԺר¼Òµ±Ñ¡ÖÐÒ½2015-11-18
- ¡¤Ê¦³ÐÃûÀÏÖÐÒ½ ´«³Ð¹úÒ½¾«2015-11-18
- ¡¤ËýÃǸøÓèÎÒÃǵÄÔ¶´óÓÚÎÒÃÇ2015-11-18
- ¡¤ÃÀµÏÒ½ÔººÃÒ½Éú Ò½Êõ¸ß 2015-11-18
- ¡¤ÃÀµÏÒ½ÔºÆô¶¯¡°·þÎñ°ÙÐÕ½¡2015-11-18
- ¡¤ÎÒԺר¼ÒÊÜÑû³öϯ µÚÈý½ìÐ2015-11-18
- ¡¤°®ÓдÈÐÄ´ÈÓа® µÂÓÐÉÆ¾Ù2015-11-18

- ¡¤ÈÈÁÒ×£ºØÎÒԺר¼Òµ±Ñ¡ÖÐÒ½2015-11-18
- ¡¤Í·Æ¤Éϳ¤ÁËС¸í´ñ£¬¾¿¾¹ÊÇ2019-1-12
- ¡¤Í·Æ¤Ñ÷Ƥм¶àͷƤÓÍ£¬µ£ÐÄ2019-1-8
- ¡¤3Ë꺢×ÓÍæ²ÊÄ໼ÉϽӴ¥ÐÔÆ¤2019-1-8
- ¡¤½Ó´¥ÐÔÆ¤Ñ×·¢ÉúµÄ²¿Î»£¬¿É2019-1-4
- ¡¤½Ó´¥ÐÔÆ¤Ñ×Óëʱ¾ã½ø£¬ºÜÓÐ2019-1-4
- ¡¤»´°²¹êÍ·Ñ×ÖÎÁƶàÉÙÇ®ÕâÈý2018-12-31